Brazil Lymphoma Therapeutics Market Analysis


  • Type: Oncology area
  • Published : May 2021
  • Region: LATAM
  • Country: Brazil
  • Report ID : 4531

  • Format: PPT, PDF

Brazil Lymphoma Therapeutics Market: Segmented by Therapy Type (Immunotherapy, Targeted Therapy, Chemotherapy and Others), by Drug Class (Adcetris, Opdivo, Rituxan, Imbruvica, Keytruda, Revlimid and Others) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Growth, Trends, and Forecasts (2019 – 2028)


Report Overview

The Brazil Lymphoma Therapeutics Market size stood at USD xx million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control.

Market Drivers

The main drivers of the lymphoma treatment are the increasing prevalence of all forms of cancers that includes other types of blood cancers. Lymphomas comprise of a sizeable number of blood cancer cases and there is a growing demand for advanced products the treatment. Such factors are expected to fuel the growth of the market during forecast period.

There is a growing initiative in R&D for the development of advanced therapies for the treatment of a wide range of lymphomas which includes non-Hodgkin lymphomas. Positive treatment rates as such are further expected to drive the market growth. The better diagnosis of the disease is anticipated to result in increased use of therapeutics which further drives the market growth.

Major Types of Lymphoma

Based on types, the market is categorized into Hodgkin and non-Hodgkin lymphomas. Non-Hodgkin lymphomas held the largest share owing to the presence of blockbuster drugs. Hodgkin lymphoma is expected to witness the fastest growth during the forecast period due to the label extension of existing drugs and the launch of new therapies for relapsed or refractory HL. Also, the presence of a strong product pipeline along with the expected commercialization of these products is one of the factors expected to drive growth.

1. Brazil Lymphoma Therapeutics Market Overview………………………..
A. Market Size
2. Market Growth Drivers …………………………………………………………………..
A. Increasing prevalence of all forms of cancers
B. Growing demand for advanced products
C. Growing initiative in R&D
3. Major Types of Lymphoma…………………………………………….
A. Hodgkin’s Lymphoma
B. Non-Hodgkin’s Lymphoma
4. Lymphoma Therapeutics Market Segmentation…………………………………….
A. By Therapy Type
I. Immunotherapy
II. Targeted Therapy
III. Chemotherapy
IV. Others
B. By Drug Class
I. Adcetris
II. Opdivo
III. Rituxan
IV. Imbruvica
V. Keytruda
VI. Revlimid
VII. Others
C. By Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online pharmacies
5. Lymphoma Therapeutics Major Market Share….……………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape………………………………………………………………….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………………………………
A. Abbott Laboratories Company overview, Product & Services, Strategies & Financials
B. Merck & Co. Company overview, Product & Services, Strategies & Financials
C. Takeda Pharmaceutical Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development in Lymphoma Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Therapy Type:

In terms of therapy type, the market is segmented into immunotherapy, targeted therapy, chemotherapy, and others. Immunotherapy is measured as highly successful in positive outcomes. Resulting in the dominance of immunotherapy segment in the market due to the higher revenue realization by these drugs.

The targeted therapy segment accounts for the second largest segment owing to a large number of products for lymphoma treatment. Other factors contributing to the growth of this segment during the forecast period includes the accuracy of these therapies in the targeting of the cancer.

By Drug class:

Based on drugs, the market for lymphoma treatments is segmented into Adcetris, Opdivo, Rituxan, Imbruvica, Keytruda, Revlimid, and others. Revlimid held the largest share and is expected to witness significant growth during the forecast period. Revlimid sales are being driven by an increase in the duration of cancer treatments. Rituxan/MabThera held the second-largest share owing to the increasing use of this product in multiple indications along with a high prescription rate.

By Distribution Channel:

The segmentation of the market based on distribution channels is retail pharmacies, hospital pharmacies, and online pharmacies. The reason for the dominance of hospital pharmacies segment is that the consumption of these drugs is most in hospitals and are mostly dispensed in hospital pharmacies for the hospitalized patients. This allows proper treatment under observation of healthcare professionals. Retail pharmacies are expected to register a lower CAGR comparatively because the treatment is mostly offered in hospitalised patients.

Major Players

Some of the key players in the lymphoma treatment market are Merck & Co., Inc.; F. Hoffmann-La Roche Ltd.; Takeda Pharmaceutical Company Ltd.; Johnson & Johnson; Eli Lilly and Company; and Abbott Laboratories.

Key players are adopting various strategies such as mergers & acquisitions to increase their market share. Furthermore, players are collaborating to launch their products in different regions to further strengthen their position in the market.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements